Breaking News

Pharmatek Acquires Xcelodose 600S System

February 5, 2013

Doubles manufacturing production for PIC operations

Pharmatek has purchased another Xcelodose 600S system doubling the company’s manufacturing production rate for powder-in-capsule (PIC) operations, and increasing overall preclinical and early phase clinical cGMP supply capabilities.
The Xcelodose, manufactured by Capsugel, is a precision powder micro-doser and automated encapsulator that has the ability to fill formulations or API directly into capsules. The Xcelodose can measure to levels as low as 100 micrograms and can dispense into capsules from size 00 to 4. 
“The acquisition of an additional Xcelodose unit enables Pharmatek to better serve our clients’ early phase development strategies and meet the growing demand for PIC projects,” said Kevin Rosenthal, director of manufacturing at Pharmatek. “For PIC applications, the Xcelodose can drastically decrease time to clinic while also lowering the cost of drug product for first-in-human trials.”

Related Contract Manufacturing:

Related Packaging:

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO